Response by Elliott et al to Letter Regarding Article, “Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy”

June 25, 2022 Editor

“Response by Elliott et al to Letter Regarding Article, “Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy”.” Circulation: Heart Failure, , pp. –

Footnotes

For Sources of Funding and Disclosures, see page xxx.

Source link

← Letter by Baldovino et al Regarding Article, “Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy”
The Use of Digital Technologies in the Inpatient Setting to Promote Communication During the Early Stage of an Infectious Disease Outbreak: A Scoping Review →